FI870501A - Förfarande för framställning av en antigen peptid eller ett antigent protein som härrör sig till den med melanom associerade antigenen p97 och härvid användbara rekombinantvirus, rekombinantvektorer och värdcell - Google Patents

Förfarande för framställning av en antigen peptid eller ett antigent protein som härrör sig till den med melanom associerade antigenen p97 och härvid användbara rekombinantvirus, rekombinantvektorer och värdcell Download PDF

Info

Publication number
FI870501A
FI870501A FI870501A FI870501A FI870501A FI 870501 A FI870501 A FI 870501A FI 870501 A FI870501 A FI 870501A FI 870501 A FI870501 A FI 870501A FI 870501 A FI870501 A FI 870501A
Authority
FI
Finland
Prior art keywords
antigenic
melanoma
antigen
protein
producing
Prior art date
Application number
FI870501A
Other languages
English (en)
Finnish (fi)
Other versions
FI94836C (sv
FI870501A0 (sv
FI94836B (sv
Inventor
Joseph P Brown
Gregory D Plowman
Karl E Hellstrom
Anthony F Purchio
Sridhar Pennathur
Charles D Estin
Timothy M Rose
Ingegerd Hellstrom
Shiu-Lok Hu
Original Assignee
Oncogen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26676698&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI870501(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US07/007,230 external-priority patent/US5262177A/en
Application filed by Oncogen filed Critical Oncogen
Publication of FI870501A0 publication Critical patent/FI870501A0/sv
Publication of FI870501A publication Critical patent/FI870501A/sv
Application granted granted Critical
Publication of FI94836B publication Critical patent/FI94836B/sv
Publication of FI94836C publication Critical patent/FI94836C/sv

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/5743—Specifically defined cancers of skin, e.g. melanoma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/00119—Melanoma antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/79—Transferrins, e.g. lactoferrins, ovotransferrins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
FI870501A 1986-02-07 1987-02-06 Förfarande för framställning av en antigen peptid eller ett antigent protein som härrör sig till den med melanom associerade antigenen p97 och härvid användbara rekombinantvirus, rekombinantvektorer och värdcell FI94836C (sv)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US82731386A 1986-02-07 1986-02-07
US82731386 1986-02-07
US07/007,230 US5262177A (en) 1986-02-07 1987-01-27 Recombinant viruses encoding the human melanoma-associated antigen
US723087 1987-01-27

Publications (4)

Publication Number Publication Date
FI870501A0 FI870501A0 (sv) 1987-02-06
FI870501A true FI870501A (sv) 1987-08-08
FI94836B FI94836B (sv) 1995-07-31
FI94836C FI94836C (sv) 1995-11-10

Family

ID=26676698

Family Applications (1)

Application Number Title Priority Date Filing Date
FI870501A FI94836C (sv) 1986-02-07 1987-02-06 Förfarande för framställning av en antigen peptid eller ett antigent protein som härrör sig till den med melanom associerade antigenen p97 och härvid användbara rekombinantvirus, rekombinantvektorer och värdcell

Country Status (18)

Country Link
JP (3) JP2664673B2 (sv)
BE (1) BE1000175A3 (sv)
CH (1) CH675424A5 (sv)
DE (1) DE3703702C2 (sv)
DK (1) DK63287A (sv)
ES (2) ES2012815A6 (sv)
FI (1) FI94836C (sv)
GR (1) GR870195B (sv)
HU (1) HU209144B (sv)
IE (1) IE59597B1 (sv)
IT (1) IT1222359B (sv)
MX (1) MX9203574A (sv)
NL (1) NL8700285A (sv)
NO (1) NO178931C (sv)
NZ (1) NZ219192A (sv)
OA (1) OA08478A (sv)
PT (1) PT84255B (sv)
SE (2) SE506024C2 (sv)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19821925A1 (de) * 1998-05-15 1999-11-18 Roehnisch Tim Verfahren zur Herstellung einer Zusammensetzung zur Induktion einer tumorspezifischen Immunantwort, sowie Verwendung der Zusammensetzung zur Behandlung von Neoplasien
JP4414023B2 (ja) * 1999-08-05 2010-02-10 オリエンタル酵母工業株式会社 関節炎関連メラノトランスフェリンの測定方法および試薬
JP4708027B2 (ja) * 2002-10-01 2011-06-22 ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド 抗癌組成物および抗感染疾患組成物ならびにこれらを使用する方法
US8207314B2 (en) * 2003-05-16 2012-06-26 Sanofi Pasteur Limited Tumor antigens for prevention and/or treatment of cancer

Also Published As

Publication number Publication date
MX9203574A (es) 1992-07-01
IE870319L (en) 1987-08-07
JPH08280390A (ja) 1996-10-29
NO870475D0 (no) 1987-02-06
IE59597B1 (en) 1994-03-09
ES2012815A6 (es) 1990-04-16
IT1222359B (it) 1990-09-05
CH675424A5 (en) 1990-09-28
HU209144B (en) 1994-03-28
ES2017258A6 (es) 1991-01-16
PT84255B (pt) 1989-11-30
SE506024C2 (sv) 1997-11-03
OA08478A (fr) 1988-07-29
NO178931B (no) 1996-03-25
FI94836C (sv) 1995-11-10
HUT43107A (en) 1987-09-28
JPH09135692A (ja) 1997-05-27
JP2664673B2 (ja) 1997-10-15
IT8719291A0 (it) 1987-02-06
GR870195B (en) 1987-06-10
SE8700466L (sv) 1987-08-08
SE9202934D0 (sv) 1992-10-07
DE3703702C2 (de) 1997-07-10
FI870501A0 (sv) 1987-02-06
NZ219192A (en) 1991-10-25
FI94836B (sv) 1995-07-31
NO870475L (no) 1987-08-10
DE3703702A1 (de) 1988-02-18
DK63287A (da) 1987-08-08
BE1000175A3 (fr) 1988-07-12
NL8700285A (nl) 1987-09-01
PT84255A (en) 1987-03-01
NO178931C (no) 1996-07-03
SE8700466D0 (sv) 1987-02-06
DK63287D0 (da) 1987-02-06
JPS62294698A (ja) 1987-12-22

Similar Documents

Publication Publication Date Title
AR243080A1 (es) Procedimiento para obtener un complejo inmunogenico entre proteinas antigenicas o peptidos con regiones hidrofobas y bisdesmosidos con regiones hidrofobas.
EP0433371A4 (en) Fusion protein of paramyxovirus, method of production using recombinant baculovirus expression vector, vaccine comprising such protein and use thereof
PT90312A (pt) Processo para a preparacao de novos anticorpos recombinantes e quimericos dirigidos contra um antigenio de adenocarcinoma humano
DK374087D0 (da) Fremgangsmaade til fremstilling af proteiner med faktor viii-aktivitet ved hjaelp af mikrobielle voertsceller og ekspressionsvektorer, vaertsceller og antistoffer til anvendelse ved denne
AU2445888A (en) Recombinant fowlpox virus, vectors for the expression of heterologous proteins and vaccines for poultry derived from this virus
AU6979387A (en) Fusion protein comprising influenza virus haemagglutinin and antigenic epitope
DE68917323D1 (de) Expressions-Vektor für Fusions-Proteine und Immunogen-Proteine.
NO912825L (no) Fremgangsmaate for fremstilling av kokonjugatvaksiner omfattende im munogent protein, hiv-beslektede peptider og anioniske grupper.
NO885013D0 (no) FremgangsmŸte for fremstilling av bionedbrytbare mikrokapsler av vannopplelige peptider og proteiner, samt mikroka psler oppnŸdd ved fremgangsmŸten.
DE69434413D1 (de) Fusionsproteine zwischen antigene aminosäuresequenzen und beta - 2- mikroglobulin
DK163062C (da) Antigen, immunogen, proteinholdig vaccine imod coccidiose
NO882917L (no) Fusjonsproteiner og partikler.
DK457687A (da) Antigenisk aktive proteiner og peptider, og vacciner mod virus for felin peritonitis (fipv) med indhold af saadanne proteiner eller peptider
NZ221227A (en) Hiv envelope proteins, antigenic fragments vaccines; and diagnostic methods
NO861772L (no) Fremgangsmaate for fremstilling av proteinhydrolysat.
FI870501A (sv) Förfarande för framställning av en antigen peptid eller ett antigent protein som härrör sig till den med melanom associerade antigenen p97 och härvid användbara rekombinantvirus, rekombinantvektorer och värdcell
NO892269L (no) Ikke-hyperglykosylerte hepatitt b-virus-proteiner samt ekspresjons-"kassetter" og fremgangsmaate for fremstilling avproteinene.
EP0293827A3 (en) Assay for leishmaniasis
DE3584029D1 (de) Expressionsvektoren, dns-fragmente, peptide, wirte und verfahren zur herstellung von peptiden.
PT87207A (pt) Process for preparing recombinant htlv-iii proteins and uses thereof
ZA874677B (en) Dna sequence,recombinant dna molecules and process for producing the newcastle disease virus fusion protein or equivalent polypeptides,obtained products and preparations containing same
NO178036C (no) Fremgangsmåte for fremstilling av fusjonsproteiner, genstruktur, vektorer streptomycetceller og fusjonsproteinene
DE3877136D1 (de) Rekombinantes histidinreiches protein von plasmodium falciparum, seine herstellung und verwendung.
AU596692B2 (en) DNA coding for antigen protein of rinderpest virus
DK116487A (da) Fremgangsmaade til eksponering af en epitop i et protein med bestemt polypeptidstruktur, samt vektorer til brug ved fremgangsmaaden, hybridproteiner omfattende epitopen, og anvendelse af hybridproteinet ved diagnoser.

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed

Owner name: ONCOGEN